THE Malaysian Organisation of Pharmaceutical Industries (MOPI) has called for help in the opening up of new markets for Malaysian ma- nufactured pharmaceutical products through an emphasis on PIC/S (Pharmaceutical In- spection Convention and Pharmaceutical In- spection Cooperation Scheme) compliance as well as to adopt a more stringent attitude towards importers of products from non-PIC/S countries.
MOPI said in its memorandum that in spite of having invested heavily in meeting PIC/S requirements and the accompanying higher standards, it had failed to gain significant international recognition while imports from non-PIC/S countries had continued, leading to an erosion in the market share of MOPI members.
Meanwhile, the Pharmaceutical Association of Malaysia (PhAMA) suggested the abolishment of import duties on vitamins and other health supplements.
Its memo pointed out that such products currently attracted a 10% import and 5% sales tax and which, if removed, could help make them more affordable and act as a preventive measure in the maintenance of general health.
Did you find this article insightful?